TP53 Gene Knockout Cell Lines (HEK293): A Complete Guide for Western Blot Research

The tumor suppressor protein p53—encoded by the TP53 gene—is arguably the most studied protein in cancer biology. Often called the "guardian of the genome," p53 responds to cellular stress by activating cell cycle arrest, DNA repair, or apoptosis.

When working with TP53 knockout (KO) cell lines, especially in the widely used HEK293 background, researchers gain a powerful tool to study p53-dependent pathways, test drug responses, and validate antibody specificity.

In this guide, I'll cover everything you need to know about TP53 KO HEK293 cells—from how they're made to how to validate them by Western blot.

Why TP53 Knockout in HEK293?

HEK293 cells (human embryonic kidney cells) are one of the most common mammalian cell lines in molecular biology labs. They're easy to transfect, grow quickly, and express many transgenes efficiently.

However, HEK293 cells have an important quirk: they express functional p53, but it's stabilized by the adenoviral E1A oncoproteins expressed in these cells. This means p53 is present at detectable levels—making HEK293 a suitable background for generating TP53 KO models.

Why generate TP53 KO HEK293 cells?

Available TP53 KO HEK293 Cell Lines

Several commercial and academic sources offer validated TP53 knockout HEK293 cells. Here are two examples from the Cellosaurus database:

*Note: TP53INP2 is a p53-regulated gene, not TP53 itself. This line is useful for studying p53 pathway effectors.*

For true TP53 knockout, the Ubigene HEK293 TP53 KO line targets the TP53 gene directly using CRISPR/Cas9 technology.

Research-Grade TP53 KO Models

In a 2022 genome-wide CRISPR screen, researchers used a TP53 knockout HEK293A cell line to identify genes essential for cell proliferation in the absence of p53. This demonstrates the utility of TP53 KO backgrounds for discovering synthetic lethal interactions—genes that become essential only when p53 is missing.

How TP53 KO HEK293 Cells Are Generated

The CRISPR/Cas9 Method

Most modern TP53 knockout cell lines are generated using CRISPR/Cas9 technology:

1. Design sgRNA targeting an early exon of the TP53 gene (usually exon 2 or 3)

2. Clone into Cas9-expressing plasmid (e.g., pX458 with GFP marker)

3. Transfect HEK293 cells using electroporation or lipid-based reagents

4. Select single-cell clones by limiting dilution or FACS sorting

5. Validate knockout by Western blot and DNA sequencing

Why TP53 Knockout Can Be Challenging

A bachelor's thesis from the University of Groningen (2022) reported unsuccessful TP53 knockout in HEK293 cells despite using CRISPR/Cas9. The western blot showed only a slight reduction in p53 protein levels, and sequencing revealed no mutation at the target site.

Key takeaway: TP53 knockout requires careful sgRNA design and thorough validation. Don't assume transfection equals successful knockout—always validate.

Validating TP53 Knockout by Western Blot

Western blot is the gold standard for confirming p53 protein loss in KO cell lines.

Antibody Selection

Best practice: Use two antibodies targeting different epitopes to confirm complete loss of full-length p53.

Expected Western Blot Results

Loading Controls for TP53 KO Blots

When blotting for p53, use a loading control that is not affected by p53 status:

Step-by-Step Validation Protocol

1. Lyse wild-type and TP53 KO HEK293 cells in RIPA buffer with protease inhibitors

2. Quantify protein concentration (BCA assay)

3. Load 20–30 µg total protein per lane

4. Run on 10–12% SDS-PAGE gel

5. Transfer to PVDF or nitrocellulose membrane

6. Block with 5% milk or BSA for 1 hour

7. Incubate with primary antibody (e.g., DO-1 at 1:1000) overnight at 4°C

8. Wash 3×10 minutes with TBST

9. Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour

10. Detect by ECL chemiluminescence

Critical control: Always run wild-type lysate on the same blot. A true KO should show no detectable p53 band.

p53 Status in HEK293: What You Need to Know

HEK293 cells express wild-type TP53 but with an important twist.

The E1A Effect

HEK293 cells are transformed with sheared adenovirus type 5 DNA, which includes the E1A and E1B oncogenes. E1A binds and inactivates the retinoblastoma protein (pRB), while E1B binds and inactivates p53.

However, in HEK293 cells, p53 is not completely inactivated—it's stabilized and functional. This makes HEK293 a p53-proficient line suitable for generating KO models.

p53 Activation in HEK293

When treated with DNA-damaging agents (e.g., doxorubicin, etoposide, UV radiation), wild-type HEK293 cells show a dramatic increase in p53 protein levels. This inducibility is lost in TP53 KO cells—making them an excellent negative control for genotoxicity studies.

Applications of TP53 KO HEK293 Cells

1. Antibody Validation

Isogenic KO cell lines are the gold standard for antibody validation. If a p53 antibody shows a band at ~53 kDa in wild-type HEK293 but no band in TP53 KO HEK293, the antibody is specific.

2. CRISPR Screens

Researchers have used TP53 KO HEK293A cells in genome-wide CRISPR screens to identify genes essential in p53-deficient backgrounds. This approach can reveal synthetic lethal targets for cancer therapy.

3. Drug Response Studies

Many chemotherapeutic agents work partially through p53-dependent pathways. Comparing drug responses between wild-type and TP53 KO HEK293 cells helps identify p53-dependent drug mechanisms.

4. p53 Signaling Pathway Mapping

By removing p53 entirely, researchers can study compensatory pathways and p53-independent stress responses without background p53 activity.